Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BLND NASDAQ:DOCS NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLNDBlend Labs$4.24-1.5%$3.52$2.63▼$5.53$1.12B1.253.55 million shs2.69 million shsDOCSDoximity$72.49+2.1%$63.84$39.27▼$85.21$13.58B1.372.22 million shs1.68 million shsTEMTempus AI$85.13-1.4%$68.15$31.36▼$91.45$15.01B5.079.84 million shs5.16 million shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLNDBlend Labs0.00%+6.82%+52.30%+34.98%+10.23%DOCSDoximity0.00%+2.51%+9.11%+26.81%+80.70%TEMTempus AI0.00%+8.49%+17.08%+19.97%+74.93%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLNDBlend Labs$4.24-1.5%$3.52$2.63▼$5.53$1.12B1.253.55 million shs2.69 million shsDOCSDoximity$72.49+2.1%$63.84$39.27▼$85.21$13.58B1.372.22 million shs1.68 million shsTEMTempus AI$85.13-1.4%$68.15$31.36▼$91.45$15.01B5.079.84 million shs5.16 million shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLNDBlend Labs0.00%+6.82%+52.30%+34.98%+10.23%DOCSDoximity0.00%+2.51%+9.11%+26.81%+80.70%TEMTempus AI0.00%+8.49%+17.08%+19.97%+74.93%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLNDBlend Labs 2.86Moderate Buy$4.8815.31% UpsideDOCSDoximity 2.61Moderate Buy$67.00-7.58% DownsideTEMTempus AI 2.54Moderate Buy$70.17-17.58% DownsideCurrent Analyst Ratings BreakdownLatest DOCS, BLND, TEM, and RMG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/12/2025TEMTempus AIHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$90.00 ➝ $98.009/11/2025DOCSDoximityRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$75.00 ➝ $80.009/10/2025DOCSDoximityRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$75.009/2/2025TEMTempus AIHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$90.008/22/2025BLNDBlend LabsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.258/20/2025DOCSDoximityZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/20/2025TEMTempus AIBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$75.00 ➝ $85.008/12/2025TEMTempus AIMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$65.00 ➝ $68.008/11/2025DOCSDoximityPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$65.00 ➝ $69.008/8/2025TEMTempus AIBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$60.008/8/2025TEMTempus AIPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLNDBlend Labs$162.02M6.79N/AN/A($0.22) per share-19.25DOCSDoximity$589.64M23.03$0.89 per share81.32$5.52 per share13.13TEMTempus AI$693.40M21.33N/AN/A$0.35 per share243.23Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLNDBlend Labs-$43.35M-$0.15N/AN/AN/A-14.26%N/A-4.24%11/5/2025 (Estimated)DOCSDoximity$147.58M$1.1772.4967.754.1036.60%21.75%18.64%N/ATEMTempus AI-$705.81M-$1.19N/AN/AN/A-20.98%-122.86%-18.09%11/3/2025 (Estimated)Latest DOCS, BLND, TEM, and RMG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/8/2025Q2 2025TEMTempus AI-$0.23-$0.22+$0.01-$0.25$296.84 million$314.64 million8/7/2025Q2 2025BLNDBlend Labs$0.02-$0.03-$0.05-$0.04$31.93 million$31.52 million8/7/2025N/ADOCSDoximity$0.31$0.36+$0.05N/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLNDBlend LabsN/AN/AN/AN/AN/ADOCSDoximityN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLNDBlend LabsN/A2.402.40DOCSDoximityN/A8.748.74TEMTempus AI2.581.541.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLNDBlend Labs52.56%DOCSDoximity87.19%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipBLNDBlend Labs35.52%DOCSDoximity31.30%TEMTempus AI26.27%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLNDBlend Labs1,690259.66 million167.43 millionNot OptionableDOCSDoximity890187.30 million116.87 millionNot OptionableTEMTempus AI2,400173.73 million128.09 millionN/ADOCS, BLND, TEM, and RMG HeadlinesRecent News About These CompaniesRenalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney DiseaseSeptember 15 at 8:00 AM | prnewswire.comTempus AI (NASDAQ:TEM) Price Target Raised to $98.00September 15 at 2:29 AM | americanbankingnews.comTempus AI, Inc. $TEM Shares Acquired by Salem Investment Counselors Inc.September 14 at 5:17 AM | marketbeat.comTempus AI (NASDAQ:TEM) Given New $98.00 Price Target at HC WainwrightSeptember 13 at 8:14 AM | marketbeat.comNewEdge Advisors LLC Has $1.76 Million Stock Position in Tempus AI, Inc. $TEMSeptember 13 at 3:31 AM | marketbeat.comTempus AI stock is cheap as Murrey Math Lines points to more gainsSeptember 12 at 6:21 PM | invezz.comIArtificial Intelligence Stocks To Watch Now - September 11thSeptember 12 at 1:40 PM | marketbeat.comTraders Buy High Volume of Tempus AI Call Options (NASDAQ:TEM)September 12 at 1:24 PM | marketbeat.comTempus AI: Is TEM Stock A 10x Growth Story?September 12 at 1:20 PM | forbes.comTempus AI (TEM) Touches 7-Month High on Pixel FDA ApprovalSeptember 12 at 10:30 AM | insidermonkey.comTempus (TEM) Stock Jumps 13.6%: Will It Continue to Soar?September 12 at 9:46 AM | zacks.comTempus AI: Temporarily Too Expensive - SellSeptember 12 at 9:05 AM | seekingalpha.comArete Wealth Advisors LLC Makes New $314,000 Investment in Tempus AI, Inc. $TEMSeptember 12 at 4:19 AM | marketbeat.comTempus AI Target of Unusually Large Options Trading (NASDAQ:TEM)September 12 at 2:43 AM | americanbankingnews.comCathie Wood’s ARK buys Klarna stock, sells Tempus AI amid market shiftsSeptember 11, 2025 | investing.comTempus Shares Jump on FDA's Special Clearance for Tempus PixelSeptember 11, 2025 | marketwatch.comTempus AI stock soars after FDA clearance for cardiac imaging platformSeptember 11, 2025 | za.investing.comTempus AI Shares Jump After FDA Approves Updated Cardiac Imaging PlatformSeptember 11, 2025 | msn.comWhy Tempus AI Stock Soared Nearly 14% Higher TodaySeptember 11, 2025 | fool.comNorthwestern Medicine Integrates Tempus AI’s “David” Clinical Assistant into EHR PlatformSeptember 11, 2025 | insidermonkey.comTempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac ImagingSeptember 11, 2025 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesNVIDIA Stock Could Pull Back in September, But Don’t Bet on ItBy Thomas Hughes | August 28, 2025Top 5 September Stock Picks: Market Tailwinds Drive New MomentumBy Thomas Hughes | September 1, 2025What to Expect From the Q3 Reporting SeasonBy Thomas Hughes | September 3, 20253 Gold ETFs That Could Surge If the Fed Cuts Rates This MonthBy Jordan Chussler | September 1, 2025New Age Warfare: Anduril Is the Hype, AeroVironment Is the BuyBy Jeffrey Neal Johnson | August 28, 2025DOCS, BLND, TEM, and RMG Company DescriptionsBlend Labs NYSE:BLND$4.24 -0.07 (-1.51%) Closing price 03:59 PM EasternExtended Trading$4.26 +0.02 (+0.47%) As of 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Blend Labs, Inc. engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty. It also offers verification components to automate confirmation tasks that are needed to underwrite a loan or approve the opening of a new deposit account; decisioning components to reduce the need for human intervention by automatically applying business rules throughout an application workflow configured by a financial services firm; workflow intelligence components to manage data collection and automate tasks throughout the loan origination process; and marketplace components to enable consumers to shop for products and services presented at the precise moment of need during an application for a loan. In addition, the company, through its subsidiary, offers title search procedures for title insurance policies, escrow, and other closing and settlement services, as well as other trustee services; and provides professional and consulting services. It serves banks, credit unions, fintechs, and non-bank mortgage lenders. The company was incorporated in 2012 and is headquartered in San Francisco, California.Doximity NASDAQ:DOCS$72.49 +1.46 (+2.06%) Closing price 03:59 PM EasternExtended Trading$72.50 +0.00 (+0.00%) As of 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Tempus AI NASDAQ:TEM$85.13 -1.25 (-1.45%) Closing price 04:00 PM EasternExtended Trading$84.92 -0.21 (-0.25%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Royal Caribbean's 33% Dividend Hike Signals Deeper Growth FuelCell Energy's Stock: Is a Fundamental Breakout Underway? After a Strong Wall Street Debut, Klarna's Real Work Begins MarketBeat Week in Review – 09/08 - 09/12 Adobe’s Rebound Has Room to Run: 25% Upside by Year-End Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
